Clinical Trial Update: Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial of oregovomab plus chemotherapy for newly diagnosed advanced epithelial ovarian cancer after optimal debulking surgery is currently active and n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Oregovomab (oregovomab)

Snippet

Sponsor: CanariaBio Inc. | Conditions: Carcinoma, Ovarian Epithelial, Ovarian Neoplasms | Phase 3 | Status: ACTIVE_NOT_RECRUITING